Evidence map›Paper›PMID 40508142›Full record

ArticleInternational journal of molecular sciences2025

The 8-Hydroxyquinoline Derivatives of 1,4-Naphthoquinone: Synthesis, Computational Analysis, and Anticancer Activity.

Arkadiusz Sokal, Roman Wrzalik, Małgorzata Latocha, Monika Kadela-Tomanek

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Arkadiusz SokalDepartment of Organic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 4 Jagiellońska Str., 41-200 Sosnowiec, Poland.ORCID 0009-0000-5299-317X
Roman WrzalikSilesian Center for Education and Interdisciplinary Research, University of Silesia, 75Pułku Piechoty 1a, 41-500 Chorzów, Poland.
Małgorzata LatochaDepartment of Cell Biology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 8 Jedności Str., 41-200 Sosnowiec, Poland.ORCID 0000-0003-4109-2629
Monika Kadela-TomanekDepartment of Organic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 4 Jagiellońska Str., 41-200 Sosnowiec, Poland.ORCID 0000-0001-9045-5428

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anticancer drug design has been reformed by the creation of heterocyclic hybrids. The introduction of a quinoline scaffold affects the activity, toxicity, and bioavailability of new compounds. The aim of this study was to synthesize and evaluate the biological activity of hybrids of 1,4-naphthoquinone with the 8-hydroxyquinoline moiety. The structure of the new compounds was characterized using spectroscopic methods, such as HR-MS, NMR, and IR. The analysis was supplemented by calculated NMR and IR spectra. The physicochemical properties and bioavailability of the compounds were examined using in silico methods. An analysis of reactivity descriptors showed that the compounds are good electron acceptors and exhibit high reactivity. Bioavailability properties confirm that hybrids could be good oral administration drugs. The biological potential of hybrids was examined by designation of the enzymatic conversion rate of the NQO1 protein and in vitro against cancer cell lines with overexpression of the gene encoding the NQO1 protein. The possibility of interaction between the tested ligand and the NQO1 protein was examined by molecular docking methods.

Indexed as

Antineoplastic AgentsNaphthoquinonesOxyquinolineCell Line, TumorCell ProliferationHumansMolecular Docking SimulationNAD(P)H Dehydrogenase (Quinone)1,4-naphthoquinoneAntineoplastic AgentsNAD(P)H Dehydrogenase (Quinone)NaphthoquinonesNQO1 protein, humanOxyquinoline1,4-naphthoquinoneIRNMRquinolinestructure analysis

Identifiers

PMID40508142
PMCPMC12154095

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.